BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7337720)

  • 1. Mutants of HeLa cells resistant to ouabain and cassaine: genetic evidence for the common site of action of cardiac glycosides and erythrophleum alkaloids.
    Gupta RS
    Biochem Pharmacol; 1981 Nov; 30(22):3039-44. PubMed ID: 7337720
    [No Abstract]   [Full Text] [Related]  

  • 2. Cross-resistance and biochemical studies with two classes of HeLa cell mutants resistant to cardiac glycosides. The unusual behavior of cardenolide SC4453.
    Gupta RS; Chopra A
    J Biol Chem; 1985 Jun; 260(11):6843-50. PubMed ID: 2987235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variant HeLa cells selected for their resistance to ouabain.
    Rosenberg HM
    J Cell Physiol; 1975 Feb; 85(1):135-42. PubMed ID: 1110260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a specific assay for cardiac glycoside-like compounds based on cross-resistance of human cell mutants.
    Gupta RS; Chopra A; Trott AB
    Biochem Pharmacol; 1989 Jul; 38(13):2159-68. PubMed ID: 2735954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical and cross-resistance studies with HeLa cell mutants resistant to cardiac glycoside SC4453. Regulation of the resistant form of Na+/K+-ATPase in the mutant cells.
    Chopra A; Gupta RS
    J Biol Chem; 1986 Feb; 261(5):2034-40. PubMed ID: 3003091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new, alkylating derivative of cassaine.
    Raben RH; Wassermann O
    Arzneimittelforschung; 1974 Jun; 24(6):956-7. PubMed ID: 4277337
    [No Abstract]   [Full Text] [Related]  

  • 7. Cassaine: mechanism of inhibition of Na+ +K+ -ATPase and relationship of this inhibition to cardiotonic actions.
    Tobin T; Akera T; Brody SL; Ku D; Brody TM
    Eur J Pharmacol; 1975; 32(02):133-45. PubMed ID: 125204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absence of gene amplification in human cell mutants resistant to cardiac glycosides.
    Dudani AK; Gupta RS
    Mol Cell Biochem; 1987 Nov; 78(1):73-9. PubMed ID: 2457797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [New aspects on the mode of action of cardiac glycosides].
    Fricke U
    Fortschr Med; 1976 Nov; 94(32):1037-45. PubMed ID: 136410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiotonic and antiveratrinic action of Thevetia neriifolia Juss glycosides compared with ouabain and their structure activity relationship.
    Gupta OP; Misra KC; Arora RB
    Indian J Exp Biol; 1974 Sep; 12(5):399-401. PubMed ID: 4448490
    [No Abstract]   [Full Text] [Related]  

  • 11. Cardiac glycoside-induced cell death and Rho/Rho kinase pathway: Implication of different regulation in cancer cell lines.
    Özdemir A; Şimay YD; İbişoğlu B; Yaren B; Bülbül D; Ark M
    Steroids; 2016 May; 109():29-43. PubMed ID: 27017918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular basis for the insensitivity of the Monarch (Danaus plexippus) to cardiac glycosides.
    Holzinger F; Frick C; Wink M
    FEBS Lett; 1992 Dec; 314(3):477-80. PubMed ID: 1334851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of action of cardiac glycosides.
    Godfraind T
    Eur Heart J; 1984 Dec; 5 Suppl F():303-8. PubMed ID: 6099806
    [No Abstract]   [Full Text] [Related]  

  • 14. [The interaction of cardiac glycosides, tetrandrine and Ca2+ on the guinea pig heart (author's transl)].
    Chen YY; Lu FH
    Yao Xue Xue Bao; 1982 Jan; 17(1):8-11. PubMed ID: 7090833
    [No Abstract]   [Full Text] [Related]  

  • 15. Human cell mutants affected in the interaction of the 12 beta-OH group of cardiac glycosides with the digitalis receptor.
    Gupta RS; Chopra A
    Biochem Pharmacol; 1987 Nov; 36(22):3829-33. PubMed ID: 2825704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the cardiotonic response of ouabain, androstan-3-one, 16-dehydroprogesterone, and conjugated estrogens.
    Woods A; Martinez TT
    Proc West Pharmacol Soc; 1991; 34():113-5. PubMed ID: 1664956
    [No Abstract]   [Full Text] [Related]  

  • 17. [Comparative studies on the cardiotonic action of corchoroside A, ouabain and strophanthin K on the heart-lung preparation of guinea pig and cat (author's transl)].
    Rao MR; Liu TP; Meng ZJ
    Yao Xue Xue Bao; 1979; 14(5):257-66. PubMed ID: 506725
    [No Abstract]   [Full Text] [Related]  

  • 18. Binding properties and biological effects of oxidized-ouabain on cultured neonatal-rat cardiac myocytes. Implications on the mechanism of action of the digitalis-glycosides.
    Hallaq H; Heller M; Panet R; Eilam Y
    Biochem Pharmacol; 1991 Feb; 41(4):509-19. PubMed ID: 1847634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions of cardiac glycosides with cardiac cells. III. Alterations in the sensitivity of (Na+ +K+)-ATPase to inhibition by ouabain in rat hearts.
    Schwalb H; Dickstein Y; Heller M
    Biochim Biophys Acta; 1982 Jul; 689(2):241-8. PubMed ID: 6126212
    [No Abstract]   [Full Text] [Related]  

  • 20. The influence of the position of attachment of the lactone ring to the steroid nucleus on the action of cardiac glycosides.
    Mendez R; Pastelin G; Kabela E
    J Pharmacol Exp Ther; 1974 Jan; 188(1):189-97. PubMed ID: 4809267
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.